Holland Capital invests in Data platform for medical research
Amsterdam/Düsseldorf, 19 December 2023 – Holland Capital invests in German company Honic for further development of their medical data platform.
Using this funding, Honic is able to further roll out its medical data platform. The platform – developed in cooperation with the German privacy regulator and various patient groups – is live since early 2022. The first research projects with universities and international life science companies have already been successfully conducted and completed. In cooperation with renowned partners such as Bundesdruckerei as data handler, IT security company Secunet, and Schwarz Group’s cloud provider StackIT, Honic offers a completely independent solution with its data platform.
Holland Capital led this funding round. Existing investors such as Dieter von Holtzbrinck Ventures, adesso Ventures and Isartal Ventures also participated in this round.
“In recent months, we have shown that the Honic platform is capable of making routinely collected medical data from routine care available for further research. With Holland Capital’s investment, we will further expand the Honic data infrastructure and unlock new data sources to play a pivotal role in the emerging European Health Data Space (EHDS),” said dr. Henrik Matthies, CEO and co-founder of Honic.
“Honic is unique in the European health tech scene as it has been able to develop a data infrastructure aligned with the privacy regulator that can enable large-scale, interdisciplinary medical research. This enables medical research using routinely collected data which is aggregated from different sources . We are delighted to be involved in the next phase of Honic,” said Jan-Frens van Giessel, partner at Holland Capital.
“Holland Capital reinforces Honic’s mission to expand medical science in Germany and Europe. In addition to its financial investment, Holland Capital’s team also supports us with their vast experience and expertise. I am very pleased that we were able to attract international experts such as Harm-Jan Wessels and Achim Plückebaum for the board of Honic,” said Prof. med Jörg F. Debatin, MBA, chairman of the board and co-founder of Honic.
About Honic
Honic was founded by dr. Henrik Matthies and prof. dr. med J. F. Debatin, MBA. The platform, developed in cooperation with the privacy regulator in Germany, uses a unique concept allowing anonymized medical data to be aggregated to generate “Real World” insights for medical research. Since 2022, the platform has been live and successful research projects with universities and international life science companies have been conducted.
About Holland Capital
Over the past 40 years Holland Capital has invested responsibly and successfully in more than 180 Dutch SMEs. With a clear investment strategy it is active in the attractive growth markets Healthcare, Technology and Agrifood. The experienced and committed investment team knows what entrepreneurship is all about. It aims for an open, sustainable and professional relationship with the management teams of the companies it invests in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.
Holland Venture’s portfolio company Highcare invests in educational institute Latona
Amsterdam, 22 January 2018 – Highcare, the temporary employment- and secondment agency in the healthcare and safety domain, acquired the activities from Latona. Latona provides organisational- and educational advisory services in primary care. The last few years,...
Holland Venture provides growth capital to rehabilitation clinic Ortius
Amsterdam, January 11th 2018 - Private equity firm Holland Venture provides growth capital to Ortius, a progressive clinic providing specialised pain rehabilitation treatments. The investment allows Ortius to further develop their provided care and therefore realise...
Medical Artificial Intelligence company Quantib receives capital injection of EUR 4.5 million
Faster and more objective diagnoses by automatic interpretation of MRI and CT scan data Chicago, 27 November 2017 – At the world’s largest radiology conference (RSNA), medical Artificial Intelligence (AI) company Quantib announced today that it secured €4.5mln ($...
Inno4Life receives funding for serialization in pharmacy and international growth
BOM, TIIN Capital, Holland Venture and the Zeeuws Investment Fund (ZIF) invest in life science machine building company.Breda, September 4, 2017 - Inno4Life, machine building company in the life science industries, will receive an investment from the Brabant...
Cloud services platform Eshgro receives capital injection from Holland Venture
Amsterdam, 4th of July 2017 – Growth capital investor Holland Venture invests in Eshgro, a leading and innovative cloud services platform. The growth capital investment enables Eshgro to further develop its unique platform and accelerate its international growth.Cloud...
Walter Balestra shares his experiences on the fast-growing organization ZorgDomein Nederland
Amsterdam, 21st of March 2017 – During the third Holland Venture Growth Session, Walter Balestra (CEO of the fast-growing organization ZorgDomein Nederland) shared his experiences on how his organization acquired a central place in the Dutch healthcare landscape. For...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl